What’s the White Paper about?

To achieve savings, health plans must view a claim payment as an output of the inter-relationships between drug, diagnosis, dosing, unit, and pricing.  Part 2 of “Optimization of Specialty Drug Costs Under the Medical Benefit” provides comprehensive details on how a payor can apply modest policy adjustments and some straight-forward network engagement tactics to achieve a 6% to 10% in savings thanks to tighter Medical Drug management controls.
Download the White Paper

* = required field

Part 2: Optimization of Specialty Drug Costs Under the Medical Benefit

Copyright © 2017 RJ Health Systems - All Rights Reserved



Fix the following errors: